DigiFluidic Bio-Technology
PrivateLast Round
Series A
Extension
Sep 29, 2022
Total Funding Raised
$15.45M
Company Overview
DigiFluidic Bio-Technology operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A Extension round in September 2022.
DigiFluidic Bio-Technology is a biotechnology company that develops a fully automated, programmable digital fluidic platform for a wide range of life science applications.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DigiFluidic Bio-Technology Comparables
Compare DigiFluidic Bio-Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prompt Diagnostics | 81% | |
| FluxErgy | 79% | |
| Genetic Microdevices Limited | 78% |
For institutional investors. Book with your work email.
DigiFluidic Bio-Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 29, 2022 |
For institutional investors. Book with your work email.
DigiFluidic Bio-Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Convergence | Series A Extension |
| Guangzhou Huiju Capital Equity Investment Management Co., Ltd. | Series A Extension |
| Guangzhou Qudao Asset Management | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 40% MoM.
- Apr 1, 2026
Monthly visitors increased 56% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
DigiFluidic Bio-Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DigiFluidic Bio-Technology's valuation, stock price, and market status.
Is DigiFluidic Bio-Technology a public or private company?
DigiFluidic Bio-Technology is a private company.
What is the current stock price of DigiFluidic Bio-Technology?
DigiFluidic Bio-Technology is a private company, so its shares have no public market price. Caplight tracks DigiFluidic Bio-Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DigiFluidic Bio-Technology worth (valuation)?
Valuation information for DigiFluidic Bio-Technology is not publicly available.
Can I buy DigiFluidic Bio-Technology stock?
DigiFluidic Bio-Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DigiFluidic Bio-Technology's last funding round?
DigiFluidic Bio-Technology's most recent funding round was Series A Extension on September 29, 2022.
Who are the main investors in DigiFluidic Bio-Technology?
Key investors in DigiFluidic Bio-Technology include Guangzhou Qudao Asset Management.
Will DigiFluidic Bio-Technology IPO soon?
No public IPO plans have been announced for DigiFluidic Bio-Technology.
How can I track DigiFluidic Bio-Technology secondary market activity?
Caplight tracks bids, offers, and trades in DigiFluidic Bio-Technology's shares on secondary markets.